Found: 31
Select item for more details and to access through your institution.
Prognostic impact of PD-L1 and TIGIT expression in non-small cell lung cancer following concurrent chemo-radiotherapy.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-29724-4
- By:
- Publication type:
- Article
Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM).
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, p. 472, doi. 10.1245/s10434-013-3399-2
- By:
- Publication type:
- Article
Circulating Endothelial Cell (CEC) as a Diagnostic and Prognostic Marker in Malignant Pleural Mesothelioma (MPM).
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2012, v. 19, n. 13, p. 4229, doi. 10.1245/s10434-012-2506-0
- By:
- Publication type:
- Article
Frequency of epidermal growth factor receptor mutations in Bangladeshi patients with adenocarcinoma of the lung.
- Published in:
- International Journal of Clinical Oncology, 2014, v. 19, n. 1, p. 45, doi. 10.1007/s10147-012-0515-4
- By:
- Publication type:
- Article
Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy.
- Published in:
- International Journal of Clinical Oncology, 2012, v. 17, n. 1, p. 33, doi. 10.1007/s10147-011-0368-2
- By:
- Publication type:
- Article
Detection of Circulating Tumor Cells in Fluorescence Microscopy Images Based on ANN Classifier.
- Published in:
- Mobile Networks & Applications, 2020, v. 25, n. 3, p. 1042, doi. 10.1007/s11036-018-1121-0
- By:
- Publication type:
- Article
Perioperative pirfenidone treatment for lung cancer patients with idiopathic pulmonary fibrosis.
- Published in:
- Surgery Today, 2020, v. 50, n. 5, p. 469, doi. 10.1007/s00595-019-01923-5
- By:
- Publication type:
- Article
A liquid biopsy in primary lung cancer.
- Published in:
- Surgery Today, 2019, v. 49, n. 1, p. 1, doi. 10.1007/s00595-018-1659-2
- By:
- Publication type:
- Article
Adjuvant therapy following surgery in non-small cell lung cancer (NSCLC).
- Published in:
- Surgery Today, 2016, v. 46, n. 1, p. 25, doi. 10.1007/s00595-015-1174-7
- By:
- Publication type:
- Article
Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer†.
- Published in:
- Interactive Cardiovascular & Thoracic Surgery, 2014, v. 18, n. 6, p. 775, doi. 10.1093/icvts/ivu048
- By:
- Publication type:
- Article
Prognostic impact of PD-L1 expression in correlation with neutrophil-to-lymphocyte ratio in squamous cell carcinoma of the lung.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-019-57321-x
- By:
- Publication type:
- Article
Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Programmed death‐ligand 1 (PD‐L1) expression in pleomorphic carcinoma of the lung.
- Published in:
- Journal of Surgical Oncology, 2018, v. 117, n. 7, p. 1563, doi. 10.1002/jso.25041
- By:
- Publication type:
- Article
Circulating Tumor Cell Count Can Be a Useful Prognostic Factor in Lung Resection via Cardiopulmonary Bypass.
- Published in:
- Case Reports in Oncology, 2017, v. 10, n. 1, p. 169, doi. 10.1159/000457116
- By:
- Publication type:
- Article
Achievement of Cure with Gefitinib in Advanced Lung Adenocarcinoma Harboring an Activating EGFR Mutation: A Case Report.
- Published in:
- Case Reports in Oncology, 2016, v. 9, n. 3, p. 565, doi. 10.1159/000449371
- By:
- Publication type:
- Article
Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancer.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00350-7
- By:
- Publication type:
- Article
HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-021-00250-8
- By:
- Publication type:
- Article
HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-021-00250-8
- By:
- Publication type:
- Article
Detection of Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM) with the "Universal" CTC-Chip and An Anti-Podoplanin Antibody NZ-1.2.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 4, p. 888, doi. 10.3390/cells9040888
- By:
- Publication type:
- Article
Mediastinal Tracheostoma for Treatment of Tracheostenosis after Tracheostomy in a Patient with Mucopolysaccharidosis-Induced Tracheomalacia.
- Published in:
- Case Reports in Surgery, 2017, p. 1, doi. 10.1155/2017/2312415
- By:
- Publication type:
- Article
Salvage surgery combined with descending aorta resection for lung cancer.
- Published in:
- Surgical Case Reports, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1186/s40792-019-0675-9
- By:
- Publication type:
- Article
Fenestration without rib resection for postoperative bronchopleural fistula.
- Published in:
- Surgical Case Reports, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1186/s40792-019-0629-2
- By:
- Publication type:
- Article
Major pathologic response to alectinib in ALK-rearranged adenocarcinoma of the lung.
- Published in:
- Surgical Case Reports, 2018, v. 4, n. 1, p. 0, doi. 10.1186/s40792-018-0430-7
- By:
- Publication type:
- Article
CD155 expression and its clinical significance in non-small cell lung cancer.
- Published in:
- Oncology Letters, 2022, v. 23, n. 5, p. 1, doi. 10.3892/ol.2022.13286
- By:
- Publication type:
- Article
Novel circulating tumor cell-detection chip combining conventional podoplanin and EGFR antibodies for all histological malignant pleural mesothelioma.
- Published in:
- Oncology Letters, 2021, v. 22, n. 1, p. N.PAG, doi. 10.3892/ol.2021.12783
- By:
- Publication type:
- Article
Capture of mesothelioma cells with 'universal' CTC-chip.
- Published in:
- Oncology Letters, 2018, v. 15, n. 2, p. 2635, doi. 10.3892/ol.2017.7619
- By:
- Publication type:
- Article
Prognostic impact of circulating tumor cells detected with the microfluidic "universal CTC‐chip" for primary lung cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 1028, doi. 10.1111/cas.15255
- By:
- Publication type:
- Article
Detection of circulating tumor cells with a novel microfluidic system in malignant pleural mesothelioma.
- Published in:
- Cancer Science, 2019, v. 110, n. 2, p. 726, doi. 10.1111/cas.13895
- By:
- Publication type:
- Article
Podoplanin: An emerging cancer biomarker and therapeutic target.
- Published in:
- Cancer Science, 2018, v. 109, n. 5, p. 1292, doi. 10.1111/cas.13580
- By:
- Publication type:
- Article
Enhanced capture system for mesenchymal‑type circulating tumor cells using a polymeric microfluidic device 'CTC‑Chip' incorporating cell‑surface vimentin.
- Published in:
- Oncology Reports, 2024, v. 52, n. 5, p. N.PAG, doi. 10.3892/or.2024.8815
- By:
- Publication type:
- Article
EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
- Published in:
- Oncology Reports, 2017, v. 37, n. 1, p. 77, doi. 10.3892/or.2016.5235
- By:
- Publication type:
- Article